Lucid Diagnostics Inc
Ownership
Ownership Structure
Who owns Lucid Diagnostics Inc (LUCD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.7% of the shares are freely tradable; institutional investors hold 19.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 4.64 | 8,856,844 | +0.0 | 06/30/2026 |
| BlackRock Inc | 4.39 | 8,373,117 | +80.5 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.43 | 6,556,344 | +57.8 | 06/30/2026 |
| Masters Capital Management LLC | 2.09 | 4,000,000 | +0.0 | 06/30/2026 |
| Aberdeen Group PLC | 2.00 | 3,822,997 | +4.9 | 06/30/2026 |
| Geode Capital Management, LLC | 1.98 | 3,789,948 | +68.8 | 06/30/2026 |
| Two Seas Capital LP | 1.57 | 3,000,000 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.38 | 4,547,002 | +0.0 | 09/30/2026 |
| abrdn Healthcare Opportunities | 2.31 | 4,419,935 | +0.0 | 09/30/2026 |
| iShares Russell 2000 ETF | 1.88 | 3,585,593 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.